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Fascioliasis is one of the important parasitic diseases affecting cattle2• 
An accurate determination of the loss to the cattle industry due to 
fascioliasis is not easy. However, the amount of direct loss due to 
condemnation of infested livers at time of slaughter can be estimated. 
USDA records reveal that the livers of 32% of cattle killed at the 9 
slaughterhouses on the island during 1976 were condemned because of 
fluke infestation3• This represents a direct loss to the livestock industry 
of over a million dollars. Other direct losses, such as death from fascio-
liasis, cost of medicines and treatment are harder to estimate. Losses due 
to indirect causes such as poor feed conversion and low quality meat are 
also difficult to determine. 
Control of fascioliasis is directed towards the destruction of the inter-
mediate host snail, Lymnaea cubensis, and its habitae. Flat and poorly 
drained pasturelands, very common in Puerto Rico, permit water to 
accumulate during the rainy season. Mild ambient temperature, com-
bined with high rainfall and humidity, makes control of fascioliasis in 
pastures extremely difficult. In addition, the ability of the snails to 
undergo cryptobiosis or aestivation is a problem not easy to solve. 
No effective chemotherapeutic agent to control fascioliasis is available 
at present. Hexachlorethane5, the only drug approved by the FDA for 
the treatment of fascioliasis, was withdrawn from the market because 
insufficient data on the safety and efficiency of the drug was furnished by 
the manufacturer. Albendazole6, the only flukicide being considered for 
new drug approval by the Food and Drug Administration, is effective 
only against mature liver-flukes. 
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MK -401 ( 4-amino-6- trichloroethenyl-1,3-benzenedisulfonomide), a new 
drug developed by Merck, Sharp and Dohme, is reported to be effective 
against mature and immature F. hepatica worms and has a large margin 
of safety7• It was thought worthwhile to assess the efficacy and safety of 
MK-401 when given at different dosages to calves artificially infected 
with F. hepatica and raised under the typical management conditions of 
Puerto Rico. 
A total of 20 Holstein-Friesian and Brown Swiss male and female 
calves, approximately 3 to 5 months old, were brought to the dairy farm 
at the Gurabo Experiment Substation, University of Puerto Rico. The 
calves were identified, weighed, and given "Levamisole" to expel the 
gastro-intestinal parasites. 
The 20 calves were randomly allotted to 4 groups of 5 calves each and 
given orally 500 to 600 F. hepatica metacercariae in sealed gelatin 
capsules. Two months later, Group I Control was given placebo orally 
and Groups II, III, and IV were given MK-401 per os at 3, 6, and 12 mg/ 
kg bodyweight, respectively. 
At 3 weeks after administration of the drug, all the calves were weighed 
and slaughtered. The livers were isolated and identified. The bile ducts 
were dissected, and the liver-flukes were collected and counted. The 
livers were cut into small pieces of 7.5 to 10.0 em and placed in a pail 
containing warm physiological salt solution. After 30 minutes, the liver 
fragments were removed from the pail and disposed of. The physiological 
saline solution was filtered through a sieve. The flukes were collected, 
counted, and preserved in a 70% alcohol solution. The gall bladders were 
emptied in individual beakers and the eggs of F. hepatica were collected 
and allowed to develop. 
Also a section of the duodenum, where the bile duct enters, was 
removed. Both ends of the section were tied and examined for adult F. 
hepatica. Carcass remains were doused with creoline solution and buried 
deeply under the ground. 
At 3 mg/kg bodyweight, MK-401 was less effective against F. hepatica, 
as indicated by the presence of 1 to 16 8-week-old flukes in the liver of 
the treated calves. At 6 and 12 mg/kg bodyweight, the drug had a 100% 
efficacy against F. hepatica. No adverse reaction was observed in the 
experimental calves after the drug was administered. MK-401 had no 
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ovicidal property on F. hepatica. The eggs collected from the gall bladders 
of the treated calves developed and released miracidia. 
Necropsy revealed that the calves given placebo had 19 to 120 immature 
and mature liver-flukes. 
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